Development and validation of a prognostic 9-gene signature for colorectal cancer.

Cui, Junpeng; Guo, Fangyu; Yu, Yifan; Ma, Zihuan; Hong, Yuting; Su, Junyan; Ge, Yang

Cui, Junpeng; Guo, Fangyu; Yu, Yifan; Ma, Zihuan; Hong, Yuting; Su, Junyan; Ge, Yang.

Afiliação

Cui J; Department of General Surgery, Shengjing Hospital of China Medical University, Shenyang, Liaoning, China.
Guo F; Department of Endocrinology, Shengjing Hospital of China Medical University, Shenyang, Liaoning, China.
Yu Y; Department of General Surgery, Shengjing Hospital of China Medical University, Shenyang, Liaoning, China.
Ma Z; Department of Scientific Research Projects, ChosenMed Technology Co. Ltd, Beijing, China.
Hong Y; Department of Scientific Research Projects, ChosenMed Technology Co. Ltd, Beijing, China.
Su J; Department of Scientific Research Projects, ChosenMed Technology Co. Ltd, Beijing, China.
Ge Y; Department of General Surgery, Shengjing Hospital of China Medical University, Shenyang, Liaoning, China.

Front Oncol ; 12: 1009698, 2022.

Article em En | MEDLINE | ID: mdl-36465397

Palavras-chave

RNA sequencing; colorectal cancer; prognosis; risk score; signature

Texto completo

Imprimir

XML

PubMed Links

Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Tipo de estudo: Prognostic_studies Idioma: En Revista: Front Oncol Ano de publicação: 2022 Tipo de documento: Article País de afiliação: China

Texto completo

Imprimir

XML

PubMed Links

Buscar no Google